NMI Holdings, Inc. (NASDAQ:NMIH - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven analysts that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $42.29.
Several equities analysts have recently weighed in on NMIH shares. Keefe, Bruyette & Woods decreased their target price on NMI from $43.00 to $42.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 8th. Compass Point increased their price target on NMI from $34.00 to $37.00 and gave the company a "buy" rating in a report on Friday. UBS Group cut their price target on NMI from $42.00 to $41.00 and set a "neutral" rating for the company in a report on Wednesday, February 19th. Wall Street Zen raised NMI from a "hold" rating to a "buy" rating in a report on Monday, May 5th. Finally, JPMorgan Chase & Co. cut their price target on NMI from $42.00 to $41.00 and set an "overweight" rating for the company in a report on Tuesday, April 8th.
View Our Latest Research Report on NMIH
Insiders Place Their Bets
In other NMI news, Director Michael Curry Montgomery sold 1,875 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $38.05, for a total transaction of $71,343.75. Following the completion of the sale, the director now owns 66,068 shares of the company's stock, valued at $2,513,887.40. This trade represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Norman Peter Fitzgerald sold 20,000 shares of the firm's stock in a transaction on Monday, February 24th. The stock was sold at an average price of $35.88, for a total value of $717,600.00. Following the sale, the executive vice president now directly owns 37,470 shares of the company's stock, valued at approximately $1,344,423.60. This trade represents a 34.80% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 112,152 shares of company stock valued at $4,075,617 over the last quarter. 3.00% of the stock is owned by insiders.
Institutional Investors Weigh In On NMI
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Assetmark Inc. grew its stake in shares of NMI by 12.6% in the fourth quarter. Assetmark Inc. now owns 88,010 shares of the financial services provider's stock valued at $3,235,000 after buying an additional 9,842 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of NMI by 1.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,075,428 shares of the financial services provider's stock valued at $39,533,000 after buying an additional 11,347 shares in the last quarter. Barclays PLC grew its stake in shares of NMI by 264.4% in the third quarter. Barclays PLC now owns 386,999 shares of the financial services provider's stock valued at $15,940,000 after buying an additional 280,809 shares in the last quarter. abrdn plc acquired a new stake in shares of NMI in the fourth quarter valued at $8,122,000. Finally, BNP Paribas Financial Markets grew its stake in shares of NMI by 13.3% in the fourth quarter. BNP Paribas Financial Markets now owns 127,132 shares of the financial services provider's stock valued at $4,673,000 after buying an additional 14,908 shares in the last quarter. Institutional investors and hedge funds own 94.12% of the company's stock.
NMI Price Performance
Shares of NASDAQ NMIH traded up $0.19 during midday trading on Monday, hitting $37.96. The stock had a trading volume of 672,559 shares, compared to its average volume of 549,943. The company has a market capitalization of $2.97 billion, a PE ratio of 8.57, a P/E/G ratio of 1.41 and a beta of 0.56. The stock has a 50 day simple moving average of $35.70 and a 200-day simple moving average of $36.65. NMI has a 1 year low of $31.60 and a 1 year high of $42.49. The company has a quick ratio of 0.83, a current ratio of 0.60 and a debt-to-equity ratio of 0.19.
NMI (NASDAQ:NMIH - Get Free Report) last released its earnings results on Tuesday, April 29th. The financial services provider reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.18. The business had revenue of $173.25 million for the quarter, compared to the consensus estimate of $169.04 million. NMI had a return on equity of 17.33% and a net margin of 55.32%. The business's quarterly revenue was up 10.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.08 earnings per share. On average, sell-side analysts expect that NMI will post 4.62 EPS for the current fiscal year.
About NMI
(
Get Free ReportNMI Holdings, Inc provides private mortgage guaranty insurance services in the United States. The company offers mortgage insurance services, such as primary and pool insurance; and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, internet-sourced lenders, and other non-bank lenders.
Further Reading

Before you consider NMI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NMI wasn't on the list.
While NMI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.